GLP-1 receptor activation slows gastric emptying, which can lead to constipation in certain individuals
Its being studied for both diabetes and weight management, with an FDA decision expected in late 2026
(Yup, also similar to the Wegovy pill.) If your plan doesnt include coverage for Foundayo, the card caps your monthly cost at $149 for the starting dose, $199 for 2.5 mg, and $299$349 for the higher doses
2 Other GLP-1 drugs such as Mounjaro, Ozempic, Trulicity, Rybelsus , and Victoza (including a generic version) 3 are approved for the treatment of type 2 diabetes, but not specifically for weight management
We are preparing for everything we need to do so that everybody benefits from a lower price, both in diabetes and eventually in weight management, Mr